Investors Buy High Volume of ARK Genomic Revolution ETF Put Options (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) saw unusually large options trading on Thursday. Stock investors acquired 14,158 put options on the stock. This is an increase of approximately 60% compared to the average daily volume of 8,868 put options.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ARKG. Main Management LLC raised its position in shares of ARK Genomic Revolution ETF by 21,336.6% during the 4th quarter. Main Management LLC now owns 681,469 shares of the company’s stock worth $22,359,000 after purchasing an additional 678,290 shares during the period. BNP Paribas Financial Markets boosted its stake in ARK Genomic Revolution ETF by 112.8% during the 4th quarter. BNP Paribas Financial Markets now owns 1,156,701 shares of the company’s stock valued at $37,951,000 after purchasing an additional 613,063 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 271.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock worth $21,090,000 after acquiring an additional 469,740 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of ARK Genomic Revolution ETF by 106.2% during the 4th quarter. JPMorgan Chase & Co. now owns 16,435 shares of the company’s stock worth $464,000 after acquiring an additional 281,148 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of ARK Genomic Revolution ETF by 11.2% during the 2nd quarter. Wells Fargo & Company MN now owns 2,752,614 shares of the company’s stock worth $93,837,000 after acquiring an additional 277,885 shares in the last quarter.

ARK Genomic Revolution ETF Stock Down 1.0 %

Shares of ARKG opened at $23.32 on Friday. The company has a 50 day simple moving average of $28.81 and a 200-day simple moving average of $28.43.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.